Medical marijuana, particularly cannabinoids, has shown promise in alleviating chemotherapy-induced nausea and vomiting (CINV), which can hinder nutrition and treatment adherence. By interacting with the endocannabinoid system in the brain, cannabinoids can reduce nausea and increase appetite. Clinical trials, including those highlighted in a National Cancer Institute review, have demonstrated that cannabinoids are at least as effective, if not more so, than traditional antiemetic drugs. These findings underscore the potential of medical marijuana in enhancing cancer treatment outcomes and improving quality of life for patients struggling with CINV.
Read more from mercurynews.com
